Fecal Calprotectin Combined with Blood Inflammatory Biomarkers Enhances Diagnostic Evaluation and Supports Mucosal Healing Assessment in Pediatric Crohn’s Disease

Pu Li,1,* Yu Xu,1,* Yingqin Zhou,2 Ruizhuang Sun,1 Zhidong Gu,1,3 Jun Meng1,3 1Department of Laboratory Medicine, Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Ruijin, Hainan, People’s Republic of China; 2Department of Clinical laboratory, Pujiang Hospital, Minhang Area, Shanghai, People’s Republic of China; 3Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Meng, Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201821, People’s Republic of China, Tel +86 13916232907, Email [email protected] Zhidong Gu, Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201821, People’s Republic of China, Tel +86 13801653534, Email [email protected]: Previous small-sample study suggested that fecal calprotectin (FC) combined with blood inflammatory biomarkers may aid in Crohn’s disease (CD) diagnosis. This study aimed to validate the FC’s diagnostic and mucosal healing assessment value of FC and a noninvasive composite index in pediatric CD.Patients and Methods: Patients aged 2– 17 years who underwent ileocolonoscopy for suspected or established CD were enrolled. Based on endoscopy, participants were classified into three groups: controls (functional gastrointestinal disorders), MH (mucosal healing, SES-CD < 3, indicating minimal or absent visible inflammation), and ML (mucosal lesions, SES-CD ≥ 3). Fecal and blood samples were collected before endoscopy. Group differences were assessed using Kruskal–Wallis/Dunn’s tests; correlations were evaluated via Spearman coefficients; ROC analysis was used to assess diagnostic performance. A composite index was constructed by weighting CRP, ESR, and IL-6 based on their correlations with FC.Results: Among 123 participants, FC levels significantly differed across groups (P 

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-08-14
Primary Topic
American Environmental and Regional History
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fecal Calprotectin Combined with Blood Inflammatory Biomarkers Enhances Diagnostic Evaluation and Supports Mucosal Healing Assessment in Pediatric Crohn’s Disease

Dove Medical Press (Taylor and Francis Group)
American Environmental and Regional History
article

Fecal Calprotectin Combined with Blood Inflammatory Biomarkers Enhances Diagnostic Evaluation and Supports Mucosal Healing Assessment in Pediatric Crohn’s Disease

article en

Abstract

Pu Li,1,* Yu Xu,1,* Yingqin Zhou,2 Ruizhuang Sun,1 Zhidong Gu,1,3 Jun Meng1,3 1Department of Laboratory Medicine, Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Ruijin, Hainan, People’s Republic of China; 2Department of Clinical laboratory, Pujiang Hospital, Minhang Area, Shanghai, People’s Republic of China; 3Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Meng, Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201821, People’s Republic of China, Tel +86 13916232907, Email [email protected] Zhidong Gu, Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201821, People’s Republic of China, Tel +86 13801653534, Email [email protected]: Previous small-sample study suggested that fecal calprotectin (FC) combined with blood inflammatory biomarkers may aid in Crohn’s disease (CD) diagnosis. This study aimed to validate the FC’s diagnostic and mucosal healing assessment value of FC and a noninvasive composite index in pediatric CD.Patients and Methods: Patients aged 2– 17 years who underwent ileocolonoscopy for suspected or established CD were enrolled. Based on endoscopy, participants were classified into three groups: controls (functional gastrointestinal disorders), MH (mucosal healing, SES-CD < 3, indicating minimal or absent visible inflammation), and ML (mucosal lesions, SES-CD ≥ 3). Fecal and blood samples were collected before endoscopy. Group differences were assessed using Kruskal–Wallis/Dunn’s tests; correlations were evaluated via Spearman coefficients; ROC analysis was used to assess diagnostic performance. A composite index was constructed by weighting CRP, ESR, and IL-6 based on their correlations with FC.Results: Among 123 participants, FC levels significantly differed across groups (P 

Dove Medical Press (Taylor and Francis Group)
Shanghai Jiao Tong University, Hainan Provincial Department of Science and Technology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Openalex Percentile: Top 41%
American Environmental and Regional History
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.